Evidence map›Paper›PMID 41030484›Full record

ArticleJournal of medical cases2025

Radiotherapy for Isolated Breast Myeloid Sarcoma.

Jean-Marc Bourque, Jasmine Gaudet, Arsene Manengue, Christopher Bredeson, Rajiv Samant

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medical cases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jean-Marc BourqueDepartment of Radiation Oncology, Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal, QC, Canada.
Jasmine GaudetDepartment of Medicine, Universite de Montreal, Montreal, QC, Canada.
Arsene ManengueDepartment of Radiation Oncology, Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal, QC, Canada.
Christopher BredesonDepartment of Hematology, The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada.
Rajiv SamantDepartment of Radiation Oncology, The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myeloid sarcoma (MS) is an uncommon solid extramedullary tumor composed of malignant myeloid blasts that can be located in various tissues. It is often associated with acute myeloid leukemia (AML), but it can also be found in patients suffering from myeloproliferative disorders or myelodysplastic syndrome. Despite the lack of consensus on the best treatment for MS, this tumor is acknowledged to be radiosensitive. We report the case of a 33-year-old female diagnosed with MS involving the breast treated with salvage radiation, after having initially undergone systemic chemotherapy and an allogeneic hematopoietic cell transplant. The purpose of this report is to discuss the significant impact of local radiotherapy in patients suffering from this unique condition.

Indexed as

Acute myeloid leukemiaBreast tumorHematologic malignanciesMyeloid sarcomaRadiotherapy

Identifiers

PMID41030484
PMCPMC12479078

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.